CCN1C(=O)c2ccccc2[S+]([O-])c2ccc(C(=O)NCCN(CC(C)C)CC(C)C)cc21
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?